INDSWIFT LABORATORIES
Back to Balance Sheet
|
INDSWIFT LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹0.11 Cr | ₹1.36 Cr | ₹4.24 Cr | ₹36 Cr | ₹40 Cr |
What is the latest Contingent Liabilities ratio of INDSWIFT LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹0.11 Cr |
| Mar2024 | ₹1.36 Cr |
| Mar2023 | ₹4.24 Cr |
| Mar2022 | ₹36 Cr |
| Mar2021 | ₹40 Cr |
How is Contingent Liabilities of INDSWIFT LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.11 Cr | -91.59 | |
| Mar2024 | ₹1.36 Cr | -68.05 | |
| Mar2023 | ₹4.24 Cr | -88.11 | |
| Mar2022 | ₹36 Cr | -11.00 | |
| Mar2021 | ₹40 Cr | - | |
Compare Contingent Liabilities of peers of INDSWIFT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDSWIFT LABORATORIES | ₹2,062.8 Cr | 2.8% | -3.8% | 113.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,530.0 Cr | -0.4% | 0.9% | 19.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹219,675.0 Cr | -1.2% | 21.1% | 29.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,970.0 Cr | -2.3% | 0.3% | 34.8% | Stock Analytics | |
| CIPLA | ₹117,947.0 Cr | 0.7% | 1.5% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,601.2 Cr | -0.3% | -7.1% | -3.9% | Stock Analytics | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | 2.8% |
-3.8% |
113.3% |
| SENSEX | -0.1% |
2.4% |
-3.3% |
You may also like the below Video Courses